Daniel Bensen, Chief Discovery Officer at Tyra Biosciences, Inc. (TYRA), sold 8,000 shares at $22.64 ($181K) on 2025-12-12, disclosed to the SEC on 2025-12-16.
Scheduled sale ($181k) by Chief Discovery Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TYRA | SELL | 2025-11-19 | $4.1M | — | Filing → |
| TYRA | SELL | 2025-11-17 | $4.2M | — | Filing → |
| TYRA | SELL | 2024-06-10 | $74K | — | Filing → |